mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.3 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |